Corporate Event
Date & Time:
March 24, 2025
7:00 PM – 9:00 PM ET
Format:
In Person & Virtual
What You'll Learn
7:00 – 7:15 PM | Welcome and Introduction – Clinical Relevance of Intestinal Failure-Associated Liver Disease (IFALD)
Moderator: Prof. Tim Vanuytsel (University of Leuven, Belgium)
7:15 – 7:35 PM | Pathophysiology, Clinical Manifestation, and Management of IFALD in Adults
Speaker: Prof. Manpreet Mundi (Mayo Clinic, Rochester)
7:35 – 7:55 PM | IFALD in Pediatrics: Prevention Strategies and Treatment Options
Speaker: Dr. Kathleen Gura (Boston Children’s Hospital)
7:55 – 8:15 PM | Advanced Liver Fibrosis in IFALD: Lessons Learned from Intestinal Transplants
Speaker: Prof. Kishore Iyer (Mount Sinai, New York)
8:15 – 8:35 PM | Orziloben: A Promising First-in-Class Therapy for IFALD
Speaker: Prof. Mark Puder (Boston Children’s Hospital)
8:35 – 9:00 PM | Key Takeaways and Panel Discussion
Moderator: Prof. Tim Vanuytsel
This is a non-promotional education program not accredited for Continuing Education.
Topics & Presenters
Pathophysiology, Clinical Manifestation, and Management of IFALD in Adults
Professor of Medicine
Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic
IFALD in Pediatrics: Prevention Strategies and Treatment Options
Pharmacy Clinical Research Program Manager
Boston Children's Hospital
Assistant Professor of Pediatrics
Harvard Medical School
Advanced Liver Fibrosis in IFALD: Lessons Learned from Intestinal Transplants
Professor of Surgery, Pediatrics, and Global Health
Icahn School of Medicine at Mount Sinai
Director of Adult and Pediatric Intestinal Rehabilitation and Transplantation
Mount Sinai Hospital
Orziloben: A Promising First-in-Class Therapy for IFALD
Professor of Surgery
Harvard Medical School
Attending Surgeon
Department of Surgery, Boston Children's Hospital
Moderators:
Tim Vanuytsel
Professor
University of Leuven, Belgium
Supported by NorthSea Therapeutics